Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q1 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $200 thousand.

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.